These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

273 related items for PubMed ID: 16339703

  • 21. Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients.
    Rose C, Vandevenne P, Bourgeois E, Cambier N, Ernst O.
    Eur J Haematol; 2006 Aug; 77(2):145-9. PubMed ID: 16608501
    [Abstract] [Full Text] [Related]

  • 22. Spin density projection-assisted R2 magnetic resonance imaging of the liver in the management of body iron stores in patients receiving multiple red blood cell transfusions: an audit and retrospective study in South Australia.
    Brown GC, Patton WN, Tapp HE, Taylor DJ, St Pierre TG.
    Intern Med J; 2012 Sep; 42(9):990-6. PubMed ID: 22647084
    [Abstract] [Full Text] [Related]

  • 23. [Evaluation of the efficacy of chelation therapy with deferoxamine in patients with thalassemia major].
    Rodríguez Galindo C, Ortega Aramburu JJ, Alonso JL, Albisu M, Casaldáliga J, Díaz de Heredia C, Olivé T, Bastida P.
    Med Clin (Barc); 1994 May 21; 102(19):721-4. PubMed ID: 8041200
    [Abstract] [Full Text] [Related]

  • 24. A randomized controlled 1-year study of daily deferiprone plus twice weekly desferrioxamine compared with daily deferiprone monotherapy in patients with thalassemia major.
    Aydinok Y, Ulger Z, Nart D, Terzi A, Cetiner N, Ellis G, Zimmermann A, Manz C.
    Haematologica; 2007 Dec 21; 92(12):1599-606. PubMed ID: 18055982
    [Abstract] [Full Text] [Related]

  • 25. Monitoring chelation therapy to achieve optimal outcome in the treatment of thalassaemia.
    Porter JB, Davis BA.
    Best Pract Res Clin Haematol; 2002 Jun 21; 15(2):329-68. PubMed ID: 12401311
    [Abstract] [Full Text] [Related]

  • 26. Intensive long-term intravenous iron-chelation therapy with deferoxamine in thalassemic patients.
    Cianciulli P, Forte L, Sorrentino F, Palombi M, Papa G, Marciani MG.
    Bone Marrow Transplant; 1993 Jun 21; 12 Suppl 1():5-8. PubMed ID: 8374563
    [No Abstract] [Full Text] [Related]

  • 27. Ferritin trends do not predict changes in total body iron in patients with transfusional iron overload.
    Puliyel M, Sposto R, Berdoukas VA, Hofstra TC, Nord A, Carson S, Wood J, Coates TD.
    Am J Hematol; 2014 Apr 21; 89(4):391-4. PubMed ID: 24347294
    [Abstract] [Full Text] [Related]

  • 28. Subcutaneous bolus injection of deferoxamine is an alternative method to subcutaneous continuous infusion.
    Yarali N, Fişgin T, Duru F, Kara A, Ecin N, Fitoz S, Erden I.
    J Pediatr Hematol Oncol; 2006 Jan 21; 28(1):11-6. PubMed ID: 16394886
    [Abstract] [Full Text] [Related]

  • 29. Self-reported level of and factors influencing the compliance to desferrioxamine therapy in multitransfused thalassaemias.
    Lee WS, Toh TH, Chai PF, Soo TL.
    J Paediatr Child Health; 2011 Aug 21; 47(8):535-40. PubMed ID: 21392144
    [Abstract] [Full Text] [Related]

  • 30. The effect of desferrioxamine chelation versus no therapy in patients with non transfusion-dependent thalassaemia: a multicenter prospective comparison from the MIOT network.
    Ricchi P, Meloni A, Pistoia L, Spasiano A, Spiga A, Allò M, Gamberini MR, Lisi R, Campisi S, Peluso A, Missere M, Renne S, Mangione M, Positano V, Pepe A.
    Ann Hematol; 2018 Oct 21; 97(10):1925-1932. PubMed ID: 29926157
    [Abstract] [Full Text] [Related]

  • 31. Behavioral contracting to improve adherence in patients with thalassemia.
    Koch DA, Giardina PJ, Ryan M, MacQueen M, Hilgartner MW.
    J Pediatr Nurs; 1993 Apr 21; 8(2):106-11. PubMed ID: 8509968
    [Abstract] [Full Text] [Related]

  • 32. Comparison of subcutaneous infusion needles for transfusion-dependent thalassemia patients by the intrapersonal cross-over assessment model.
    Chan GC, Ng DM, Fong DY, Ha SY, Lau YL.
    Am J Hematol; 2004 Aug 21; 76(4):398-404. PubMed ID: 15282678
    [Abstract] [Full Text] [Related]

  • 33. Severe iron overload in Blackfan-Diamond anemia: a case-control study.
    Roggero S, Quarello P, Vinciguerra T, Longo F, Piga A, Ramenghi U.
    Am J Hematol; 2009 Nov 21; 84(11):729-32. PubMed ID: 19810012
    [Abstract] [Full Text] [Related]

  • 34. Toxic effects of high-dose deferoxamine treatment in patients with iron overload: an electrophysiological study of cerebral and visual function.
    Marciani MG, Cianciulli P, Stefani N, Stefanini F, Peroni L, Sabbadini M, Maschio M, Trua G, Papa G.
    Haematologica; 1991 Nov 21; 76(2):131-4. PubMed ID: 1937171
    [Abstract] [Full Text] [Related]

  • 35. [Therapeuetic management of patients with thalassemia major].
    Thuret I.
    Bull Soc Pathol Exot; 2001 May 21; 94(2):95-7. PubMed ID: 11475036
    [Abstract] [Full Text] [Related]

  • 36. Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients.
    Pakbaz Z, Fischer R, Fung E, Nielsen P, Harmatz P, Vichinsky E.
    Pediatr Blood Cancer; 2007 Sep 21; 49(3):329-32. PubMed ID: 17554789
    [Abstract] [Full Text] [Related]

  • 37. Compliance of deferoxamine injection in beta-thalassaemia major patients in Iran.
    Rashid M, Karimi M.
    Transfus Med; 2012 Apr 21; 22(2):104-7. PubMed ID: 22212011
    [Abstract] [Full Text] [Related]

  • 38. Retrospective nationwide survey of Japanese patients with transfusion-dependent MDS and aplastic anemia highlights the negative impact of iron overload on morbidity/mortality.
    Takatoku M, Uchiyama T, Okamoto S, Kanakura Y, Sawada K, Tomonaga M, Nakao S, Nakahata T, Harada M, Murate T, Ozawa K, Japanese National Research Group on Idiopathic Bone Marrow Failure Syndromes.
    Eur J Haematol; 2007 Jun 21; 78(6):487-94. PubMed ID: 17391310
    [Abstract] [Full Text] [Related]

  • 39. Long-term efficacy of deferoxamine iron chelation therapy in adults with acquired transfusional iron overload.
    Schafer AI, Rabinowe S, Le Boff MS, Bridges K, Cheron RG, Dluhy R.
    Arch Intern Med; 1985 Jul 21; 145(7):1217-21. PubMed ID: 3925909
    [Abstract] [Full Text] [Related]

  • 40. Advances in the use of iron-chelating agents for the treatment of iron overload.
    Modell B.
    Prog Hematol; 1979 Jul 21; 11():267-312. PubMed ID: 392593
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.